| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Epperly Melissa B, is a Chief Financial Officer at ZNTL, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 53 sales. Those positions are worth an estimated $5.7M at current prices.
Our model assigns Epperly Melissa B, a strong insider score of 72/100, based on 13 past trades. Over a 12-month horizon, 76.9% of those trades were profitable, with an average 12-month return of +39.0%.
Epperly Melissa B,'s largest disclosed position is in ZNTL as Chief Financial Officer, worth about $5.2M. The recent filings there lean toward selling, a net 69,412 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ROIV Roivant Sciences Ltd. | Director | Sale+OE | 17,750 | $36.10 | $640,861.00 | -54.3% | - | - | |
| Sep 15, 2026 | ROIV Roivant Sciences Ltd. | Director | Sell | 4,938 | $39.74 | $196,229.70 | -33.3% | - | - | |
| Jun 29, 2026 | ROIV Roivant Sciences Ltd. | Director | Sale+OE | 17,750 | $34.38 | $610,251.72 | -51.9% | +6.5% | - | |
| Mar 16, 2026 | ROIV Roivant Sciences Ltd. | Director | Sell | 41,861 | $28.68 | $1,200,573.48 | -72.6% | +6.2% | - | |
| Feb 12, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 2,573 | $11.44 | $29,435.12 | -0.6% | +2.2% | -81.9% | |
| Feb 2, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 8,669 | $11.54 | $100,040.26 | -1.9% | -4.1% | -85.0% | |
| Oct 4, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 5,482 | $19.50 | $106,925.60 | -1.4% | -19.7% | -83.9% | |
| Feb 14, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 7,851 | $20.13 | $158,004.52 | -2.0% | +39.7% | -40.4% | |
| Apr 4, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 17,080 | $50.09 | $855,522.43 | -6.5% | -41.3% | -66.5% | |
| Feb 23, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 1,913 | $49.10 | $93,920.75 | -0.7% | -56.5% | -59.7% |